Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile parkinsonism: a heterogeneous entity.

F Cardoso1, S Camargos

  • 1Movement Disorders Clinic, Department of Neurology, The Federal University of Minas Gerais, Belo Horizonte, MG, Brazil. cardosof@metalink.com.br

European Journal of Neurology
|October 29, 2000
PubMed
Summary

Juvenile Parkinsonism (JP) presents heterogeneously, often without a clear cause, and typically progresses rapidly. While L-dopa offers some benefit, many patients develop complications, highlighting the need for further research into this rare condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genotype imputation performance in Nellore cattle across different SNP panels and software tools.

Tropical animal health and production·2026
Same author

Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access.

Journal of medical economics·2026
Same author

Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: results from the randomised, global phase III CAPItello-290 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Seizing the moment: The time for harnessing electronic patient-reported outcome measures for enhanced and sustainable metastatic breast cancer care is now.

Breast (Edinburgh, Scotland)·2024

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Neurodegenerative Diseases

Background:

  • Juvenile Parkinsonism (JP) is defined as Parkinsonism with onset before age 20.
  • Understanding the clinical spectrum and natural history of JP is crucial for diagnosis and management.
  • This study investigates a cohort of JP patients to characterize their disease course.

Observation:

  • Six patients (five male, one female) with JP were studied, with a mean onset age of 12.5 years.
  • Common symptoms included bradykinesia, rigidity, postural instability, and tremor; dystonia, dementia, and ophthalmoparesis were also observed.
  • Neuroimaging revealed atrophy in some patients, and Wilson's disease was ruled out.

Findings:

  • All patients showed L-dopa responsiveness, but four developed motor complications (fluctuations, dyskinesias) requiring intervention.

Related Experiment Videos

  • After a mean of 6.5 years, five patients needed assistance with daily activities, indicating rapid progression.
  • No specific cause was identified in most patients, suggesting a primary CNS degenerative process distinct from Parkinson's disease (PD) or gangliosidosis.
  • Implications:

    • JP is a complex and heterogeneous condition, often presenting with atypical features.
    • The rapid progression and L-dopa responsiveness in some cases suggest specific underlying pathologies.
    • Further research is needed to identify the causes of JP and develop targeted therapies.